ChoiceHub
05

Alveoli

The roughly 300 million air sacs where oxygen and carbon dioxide cross between air and blood — held open by a soap-like film the alveolus manufactures for itself.

How Alveoli fits together: 4 things it normally does, the 4 ways it fails, and the 4 drugs that act on those failures. Arrows run from each normal function to the failure it explains, and from each failure to the drug that answers it.What it doesWhat goes wrongWhat we giveType I cell barrierType II surfactantLaplace 2T/rType II repairNeonatal RDSAtelectasisARDSCardiogenic oedemaAntenatal steroidsExogenous surfactantOxygenLoop diuretics
Every arrow is a link in the content itself, not a decoration: each failure points back to the normal function it breaks, and each drug to the failure it answers. Hover a box to light its whole chain, or click to jump to it.Swipe the diagram to see all of it.

What it normally does

  • Type I cells are flat and enormous: they cover about 95% of the alveolar surface and thin the barrier between air and capillary blood to well under a micrometre, over a total area of around 70 m² (type I pneumocytes).

    anything that thickens that barrier or fills the sac with fluid drops oxygen transfer long before it touches carbon dioxide, because CO₂ is roughly twenty times more soluble in water and so crosses a wet, thickened barrier far more easily.

  • Type II cells are cuboidal, sit in the corners, and make surfactant — a detergent-like film of phospholipid (mainly dipalmitoylphosphatidylcholine) plus surfactant proteins, secreted onto the thin layer of water lining the sac. SP-B and SP-C are the small hydrophobic proteins that do the mechanical work of spreading the film; SP-A and SP-D are larger and act mainly in alveolar innate immunity (type II pneumocytes).

    the water lining the alveolus is stopped from pulling the walls together. Surfactant does not abolish surface tension, it lowers it dramatically — so when it is absent, inactivated or simply not yet made, alveolar stability is what fails first.

  • The pressure trying to collapse a fluid-lined sphere is 2T/r — twice the surface tension divided by the radius — so the smallest alveoli have the strongest collapsing pull. Surfactant molecules crowd closer together as an alveolus shrinks, so they drop the tension most exactly where the pull is worst (Laplace's law).

    small alveoli stay open instead of emptying into big ones, the lung stays easy to inflate (compliant), and the work of breathing stays low. Mechanical tethering between neighbouring alveoli helps too, but surfactant is what makes the tension itself radius-dependent.

  • Type II cells are also the repair cell of the alveolus — they divide and turn into type I cells after injury. They begin making surfactant around 24 weeks of gestation and only reach mature output around 34 to 36 weeks, and cortisol accelerates that timetable.

    a baby born early has a lung that is structurally close to finished but chemically unfinished, and an adult who loses type II cells to injury loses both the surfactant and the means of healing.

What goes wrong

  • A baby born before type II cells have ramped up production has too little surfactant. Surface tension goes unopposed, so at the end of every breath out the alveoli shut. Each next breath has to re-inflate collapsed lung from scratch, which takes enormous pressure, and the alveoli that stay shut are still perfused — blood passes through the lung without meeting air (shunt), so oxygen falls and giving more oxygen only partly fixes it.

    Not enough surfactant → tension unopposed → end-expiratory collapse → stiff lungs and shunt. Preterm, grunting, ground-glass CXR.

    You would find: A preterm baby, tachypnoeic within minutes to hours of birth, with grunting, nasal flaring and intercostal recession. Chest x-ray shows a uniform ground-glass lung with air bronchograms and small volumes. Around 8-9% of Australian births are preterm, and the figure among babies of Aboriginal and Torres Strait Islander mothers is roughly 14% — well above the national rate, so this burden falls unevenly.

  • After abdominal or thoracic surgery several things push the same way. Anaesthesia and lying flat drop functional residual capacity, so the dependent basal lung is compressed by the abdominal contents and the weight of the lung above it; splinting against pain removes the periodic deep breaths that both re-expand lung and stretch type II cells into releasing stored surfactant; high inspired oxygen and retained secretions let the remaining gas be absorbed. Alveoli at the smallest radius carry the greatest collapsing pressure by Laplace, so they are the ones that shut. Those segments keep their blood supply, so the result is shunt.

    Lost FRC and no deep breaths → small alveoli lose to Laplace → basal collapse with volume loss and shunt. The fix is re-expansion (deep breathing, mobilising, CPAP), not antibiotics.

    You would find: Day one to two after surgery: low oxygen saturation, reduced breath sounds and dullness at the lung bases, and a basal band of opacity on chest x-ray with signs of lost volume — a raised hemidiaphragm and crowded ribs. Mediastinal or tracheal shift towards the opacity is a feature of large lobar or whole-lung collapse rather than the usual basal postoperative kind. Unlike consolidation, volume is lost, not added.

  • A systemic insult — sepsis, aspiration, pancreatitis, major trauma — inflames the alveolar-capillary barrier. It becomes leaky, and protein-rich fluid floods the sac. Type I cells die, which both thickens the barrier and strips away the surface for gas exchange, and the plasma protein in the fluid chemically inactivates whatever surfactant is there. So you get flooding and collapse at once: heavy, stiff lungs and hypoxaemia that does not correct with oxygen.

    Leaky barrier → protein-rich flooding + surfactant inactivation + type I cell death → shunt refractory to oxygen. Bilateral infiltrates, not cardiac.

    You would find: Within a week of a known insult or of new or worsening respiratory symptoms: bilateral opacities on imaging not fully explained by effusion, collapse or nodules; hypoxaemia with a PaO₂/FiO₂ ratio at or below 300 mmHg (about 40 kPa) measured on at least 5 cmH₂O of PEEP or CPAP; and respiratory failure not fully explained by cardiac failure or fluid overload. The clinical hallmark is the amount of oxygen it takes to achieve very little.

  • Alveolar flooding in cardiogenic pulmonary oedema← from “Type I cells are flat and enormous: they cover

    A failing left ventricle raises pressure back through the left atrium into the pulmonary capillaries. Once the hydrostatic pressure exceeds what the lymphatics can drain, water is squeezed across an intact barrier into the interstitium and then into the alveolus. The barrier is not damaged here — it is simply being outpushed — and the water sitting on the type I cells is now the diffusion distance oxygen must cross.

    Raised capillary hydrostatic pressure across an intact barrier → transudate into the alveolus → widened diffusion distance. Treat the pressure, not the lung.

    You would find: Acute breathlessness worse lying flat, fine inspiratory crackles at both bases, and a chest x-ray with upper-lobe vessel prominence, Kerley B lines and perihilar shadowing. The patient is usually sitting bolt upright.

What we give, and how it works

Open a drug to see what it binds, what that does to the cell, and what you then see in the patient.

Grunting in a preterm baby is the whole page in one sign. The baby is breathing out against a partly closed glottis to hold pressure in the lung — generating their own PEEP — because the surfactant that should stop the alveoli collapsing is not there yet. It is Laplace's law failing, audibly. That is also why CPAP works: it does from outside what the grunt is trying to do from inside, and what surfactant would do chemically.

Now test whether it stuck

Reading this through is not the same as being able to reconstruct it. Every question in the bank is free, with a full debrief on each option.